In the latest session, Codexis Inc. (NASDAQ: CDXS) closed at $3.49 down -0.57% from its previous closing price of $3.51. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 447686 shares were traded.
Ratios:
For a deeper understanding of Codexis Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.61. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.14.
TD Cowen Downgraded its Outperform to Market Perform on August 07, 2023, whereas the target price for the stock was revised from $21 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 15 ’23 when Dorgan Byron L sold 20,000 shares for $2.11 per share. The transaction valued at 42,168 led to the insider holds 193,461 shares of the business.
Norrett Kevin bought 9,000 shares of CDXS for $15,479 on Sep 11 ’23. The Chief Operating Officer now owns 98,102 shares after completing the transaction at $1.72 per share. On Sep 08 ’23, another insider, DILLY STEPHEN GEORGE, who serves as the insider of the company, bought 58,479 shares for $1.73 each. As a result, the insider paid 100,952 and bolstered with 438,878 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 248.17M and an Enterprise Value of 199.08M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.50 while its Price-to-Book (P/B) ratio in mrq is 2.82. Its current Enterprise Value per Revenue stands at 2.84 whereas that against EBITDA is -4.44.
Stock Price History:
Over the past 52 weeks, CDXS has reached a high of $4.91, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 3.2008, while the 200-Day Moving Average is calculated to be 2.5522.
Shares Statistics:
For the past three months, CDXS has traded an average of 627.93K shares per day and 519.07k over the past ten days. A total of 69.91M shares are outstanding, with a floating share count of 67.25M. Insiders hold about 4.34% of the company’s shares, while institutions hold 79.68% stake in the company. Shares short for CDXS as of Mar 15, 2024 were 2.29M with a Short Ratio of 3.65, compared to 2.52M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.26% and a Short% of Float of 3.33%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.22, while EPS last year was -$0.34. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.18 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.57 and -$0.74 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.68, with 6 analysts recommending between -$0.53 and -$0.83.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $13.81M this quarter.It ranges from a high estimate of $15M to a low estimate of $11.79M. As of the current estimate, Codexis Inc.’s year-ago sales were $12.98M, an estimated increase of 6.40% from the year-ago figure.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $71M, while the lowest revenue estimate was $58.88M, resulting in an average revenue estimate of $65.38M. In the same quarter a year ago, actual revenue was $70.14M, down -6.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $62.05M in the next fiscal year. The high estimate is $72.5M and the low estimate is $51M. The average revenue growth estimate for next year is down -5.10% from the average revenue estimate for this year.
